FIRMQUARRYResearch workspace

GOVERNMENT CONTRACT / PURCHASE ORDER

QTY.10: RETRONETIN, CAT #: T202, 2.5 ML/VIAL

Awarded to TAKARA BIO USA, INC.

PIID 75N90021P00598US · USAspendingOther
$15.1K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$15,147sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateJul 22, 2021
Company legal name
TAKARA BIO USA, INC.
UEI / CAGE
SCQNFFL3RJD9 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
National Institutes of Health
Industry
Other
NAICS
325414
PSC
6640
Performance period
Not reported — Not reported
Recipient address
2560 ORCHARD PKWY, SAN JOSE, SANTA CLARA, CA, 95131
Place of performance
MOUNTAIN VIEW, SANTA CLARA, CA, 94043
Source last modified
Nov 3, 2026

Description

QTY.10: RETRONETIN, CAT #: T202, 2.5 ML/VIAL

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    QTY.10: RETRONETIN, CAT #: T202, 2.5 ML/VIAL

    US · usaspendingSource ↗
  2. Value increased

    QTY.10: RETRONETIN, CAT #: T202, 2.5 ML/VIAL

    US · usaspending$15.1KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Jul 22, 20210Not reported$15,147.00Not reportedNot reportedQTY.10: RETRONETIN, CAT #: T202, 2.5 ML/VIALUSAspending ↗